Other languages Mind Medicine (MindMed) Inc. Deutsche Boerse AG

Equities

MMQ

CA60255C8850

Real-time Estimate Tradegate Other stock markets 05:21:35 10/05/2024 pm IST			5-day change	1st Jan Change
8.498 ^EUR	-0.72%		-4.66%	+147.64%

08/05	Transcript : Mind Medicine Inc., Q1 2024 Earnings Call, May 08, 2024
08/05	Mind Medicine Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mind Medicine Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Numinus Wellness Congratulates Mindmed on Positive Results from Phase 2B Clinical Trials of Mm120 for Generalized Anxiety Disorder	08/03
Sector Update: Health Care Stocks Gain Late Afternoon	08/03
Sector Update: Health Care Stocks Stronger in Afternoon Trading	08/03
Mind Medicine Gets FDA Breakthrough for Anxiety Treatment, Sees $175 Million in Proceeds From Stock Offerings; Shares Jump	07/03
Mind Medicine Inc. Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data from Phase 2B Study of MM120 for Generalized Anxiety Disorder	07/03
Mind Medicine Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Mind Medicine Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Mind Medicine Inc. Provides Anticipated Production Milestones for 2024	08/01
Mind Medicine Says MM-120 Shows Significant Dose-Dependent Improvements in Phase 2b Trial on Anxiety Disorder	14/12
Mind Medicine Announces Positive Topline Results from Phase 2b Trial of MM-120 in Generalized Anxiety Disorder	14/12
Mind Medicine Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03/11
Mind Medicine Inc. Completes Enrollment of Phase 2A Trial of Mm-120 in Adults with Attention-Deficit/Hyperactivity Disorder	24/23/24
Mind Medicine Completes Enrollment and Dosing in Study Mmed008	12/23/12
Mind Medicine Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04/23/04
Mind Medicine Inc Issues the Preliminary Voting Results Provided by First Coast Results, Inc	28/23/28
Mind Medicine Inc. Elects David Gryska to the Board of Directors	21/23/21
Mind Medicine Inc. Provides Overview of Clinical Progress	20/23/20
FCM MM Holdings Posts Material on Social Media Platforms	17/23/17
FCM MM Holdings Provides Information to Shareholders of Mind Medicine	16/23/16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Mind Medicine (MindMed) Inc. Deutsche Boerse AG

Equities

MMQ

CA60255C8850

Other languages

Filters